PFIZER PAYING INCYTE $25 MIL. FOR GENE DATABASE AND TECHNOLOGY ACCESS
Executive Summary
PFIZER PAYING INCYTE $25 MIL. FOR GENE DATABASE AND TECHNOLOGY ACCESS to the firm's approximately 20,000 sequenced human genes and cellular transcript imaging technology, as well as hundreds of receptors that Incyte has characterized, the companies announced June 23. Incyte said it believes it has the "world's largest compilation of detailed profiles of gene expression by numerous cells and tissues."